The Hawkins Foundation   Report issue

Foundation Phase 4
Founded: Greenville SC United States (2009)

Organization Overview

First Clinical Trial
2013
NCT01937559
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

The Hawkins Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Femoracetabular Impingement (Phase 4)

Hip Dislocation (Phase 4)

Hip Dislocation, Congenital (Phase 4)

Joint Diseases (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7